These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 2433872)
1. Topical treatment of psoriatic skin with methotrexate cream: a clinical, pharmacokinetic, and histological study. Bjerring P; Beck HI; Zachariae H; Søgaard H Acta Derm Venereol; 1986; 66(6):515-9. PubMed ID: 2433872 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of topical treatment in psoriasis with MC903, a new vitamin D analogue. Staberg B; Roed-Petersen J; Menné T Acta Derm Venereol; 1989; 69(2):147-50. PubMed ID: 2564233 [TBL] [Abstract][Full Text] [Related]
3. Treatment of psoriasis with 6-aminonicotinamide. Zackheim HS Arch Dermatol; 1975 Jul; 111(7):880-2. PubMed ID: 125068 [TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial. Salim A; Tan E; Ilchyshyn A; Berth-Jones J Br J Dermatol; 2006 Jun; 154(6):1169-74. PubMed ID: 16704650 [TBL] [Abstract][Full Text] [Related]
6. Liposomal methotrexate hydrogel for treatment of localized psoriasis: preparation, characterization and laser targeting. Ali MF; Salah M; Rafea M; Saleh N Med Sci Monit; 2008 Dec; 14(12):PI66-74. PubMed ID: 19043379 [TBL] [Abstract][Full Text] [Related]
7. The treatment of psoriasis vulgaris: 1% topical methotrexate gel. Eskicirak B; Zemheri E; Cerkezoglu A Int J Dermatol; 2006 Aug; 45(8):965-9. PubMed ID: 16911386 [TBL] [Abstract][Full Text] [Related]
8. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study. Goedkoop AY; Kraan MC; Picavet DI; de Rie MA; Teunissen MB; Bos JD; Tak PP Arthritis Res Ther; 2004; 6(4):R326-34. PubMed ID: 15225368 [TBL] [Abstract][Full Text] [Related]
9. Inefficacy of topical thyroid hormone analogue TriAc in plaque psoriasis: results of a double-blind placebo-controlled trial. Vahlquist A; Törmä H; Carlsson B Br J Dermatol; 2004 Aug; 151(2):489-91. PubMed ID: 15327560 [TBL] [Abstract][Full Text] [Related]
10. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment. Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504 [TBL] [Abstract][Full Text] [Related]
16. Treatment of chronic plaque psoriasis with dithranol and urea creams: a double-blind study. Young MM Pharmatherapeutica; 1982; 3(2):86-92. PubMed ID: 7048339 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic profile of methotrexate in psoriatic skin via the oral or subcutaneous route using dermal microdialysis showing higher methotrexate bioavailability in psoriasis plaques than in non-lesional skin. Quist SR; Quist J; Birkenmaier J; Stauch T; Gollnick HP J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1537-43. PubMed ID: 27005005 [TBL] [Abstract][Full Text] [Related]
18. Neutrophil chemotaxis in psoriasis. Wahba A; Cohen H; Bar-Eli M; Callily R Acta Derm Venereol; 1979; 59(5):441-5. PubMed ID: 93368 [TBL] [Abstract][Full Text] [Related]
19. Neutrophil and monocyte chemotaxis in methotrexate-treated psoriasis patients. Ternowitz T; Herlin T Acta Derm Venereol Suppl (Stockh); 1985; 120():23-6. PubMed ID: 3869414 [TBL] [Abstract][Full Text] [Related]
20. A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma. Pope JE; Bellamy N; Seibold JR; Baron M; Ellman M; Carette S; Smith CD; Chalmers IM; Hong P; O'Hanlon D; Kaminska E; Markland J; Sibley J; Catoggio L; Furst DE Arthritis Rheum; 2001 Jun; 44(6):1351-8. PubMed ID: 11407694 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]